NCT00243945View on ClinicalTrials.gov

A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
IDIOPATHIC PARKINSON'S DISEASE
Interventions
DRUG

Rotigotine

Trial Locations (1)

Unknown

Schwarz, Monheim

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY